关于神经氨酸酶抑制剂对死亡率有益作用的统计学和方法学问题。 - Suppr

Suppr

超能文献

Statistical and methodological concerns about the beneficial effect of neuraminidase inhibitors on mortality.

作者信息

Leonardi-Bee Jo, Venkatesan Sudhir, Muthuri Stella G, Nguyen-Van-Tam Jonathan S, Myles Puja R

机构信息

Clinical Sciences Building, University of Nottingham, City Hospital, Nottingham NG5 1PB, UK.

出版信息

Lancet Respir Med. 2014 Jul;2(7):e10-2. doi: 10.1016/S2213-2600(14)70137-7. Epub 2014 Jun 16.

DOI:10.1016/S2213-2600(14)70137-7

PMID:24948433

Abstract

摘要

相似文献

Statistical and methodological concerns about the beneficial effect of neuraminidase inhibitors on mortality.关于神经氨酸酶抑制剂对死亡率有益作用的统计学和方法学问题。

Lancet Respir Med. 2014 Jul;2(7):e10-2. doi: 10.1016/S2213-2600(14)70137-7. Epub 2014 Jun 16.

Statistical and methodological concerns about the beneficial effect of neuraminidase inhibitors on mortality.关于神经氨酸酶抑制剂对死亡率有益作用的统计学和方法学问题。

Lancet Respir Med. 2014 Jul;2(7):e8-9. doi: 10.1016/S2213-2600(14)70115-8. Epub 2014 Jun 16.

Statistical and methodological concerns about the beneficial effect of neuraminidase inhibitors on mortality.关于神经氨酸酶抑制剂对死亡率有益作用的统计学和方法学问题。

Lancet Respir Med. 2014 Jul;2(7):e9-e10. doi: 10.1016/S2213-2600(14)70126-2. Epub 2014 Jun 16.

Statistical and methodological concerns about the beneficial effect of neuraminidase inhibitors on mortality.关于神经氨酸酶抑制剂对死亡率有益作用的统计学和方法学问题。

Lancet Respir Med. 2014 Jul;2(7):e10. doi: 10.1016/S2213-2600(14)70127-4. Epub 2014 Jun 16.

Effectiveness of neuraminidase inhibitors for severe influenza.神经氨酸酶抑制剂对重症流感的疗效

Lancet Respir Med. 2014 May;2(5):346-8. doi: 10.1016/S2213-2600(14)70068-2. Epub 2014 Mar 19.

Editor in chief's reply to Nguyen-Van-Tam.主编对阮文添的回复。

BMJ. 2014 Apr 29;348:g2951. doi: 10.1136/bmj.g2951.

Study claiming Tamiflu saved lives was based on "flawed" analysis.声称达菲能挽救生命的研究基于“有缺陷的”分析。

BMJ. 2014 Mar 18;348:g2228. doi: 10.1136/bmj.g2228.

Authors' reply to Mark Jones's critique of the study by Muthuri and colleagues reported in The BMJ.

BMJ. 2014 Apr 30;348:g2990. doi: 10.1136/bmj.g2990.

Authors' reply to Mark Jones's second critique of the study by Muthuri and colleagues reported in The BMJ.

BMJ. 2014 Apr 30;348:g3004. doi: 10.1136/bmj.g3004.

Principal author of PRIDE study responds to news story in The BMJ claiming that the study was based on "flawed" analysis.PRIDE研究的主要作者回应了《英国医学杂志》上的一篇新闻报道，该报道称该研究基于“有缺陷的”分析。

BMJ. 2014 Apr 29;348:g2935. doi: 10.1136/bmj.g2935.

引用本文的文献

Early administration of neuraminidase inhibitors in adult patients hospitalized for influenza does not benefit survival: a retrospective cohort study.早期给予住院流感成人患者神经氨酸酶抑制剂对生存无益：一项回顾性队列研究。

Eur J Clin Microbiol Infect Dis. 2017 Sep;36(9):1673-1677. doi: 10.1007/s10096-017-2982-z. Epub 2017 Apr 18.

Neuraminidase Inhibitors and Hospital Mortality in British Patients with H1N1 Influenza A: A Re-Analysis of Observational Data.神经氨酸酶抑制剂与英国甲型H1N1流感患者的医院死亡率：观察性数据的重新分析

PLoS One. 2016 Sep 1;11(9):e0160430. doi: 10.1371/journal.pone.0160430. eCollection 2016.

Debate Regarding Oseltamivir Use for Seasonal and Pandemic Influenza.关于使用奥司他韦治疗季节性流感和大流行性流感的争论。

Emerg Infect Dis. 2016 Jun;22(6):949-55. doi: 10.3201/eid2206.151037.

Neuraminidase inhibitors, superinfection and corticosteroids affect survival of influenza patients.神经氨酸酶抑制剂、重叠感染和皮质类固醇会影响流感患者的生存率。

Eur Respir J. 2015 Jun;45(6):1642-52. doi: 10.1183/09031936.00169714. Epub 2015 Jan 8.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验